These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 33514561
1. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance. Rogg M, Maier JI, Dotzauer R, Artelt N, Kretz O, Helmstädter M, Abed A, Sammarco A, Sigle A, Sellung D, Dinse P, Reiche K, Yasuda-Yamahara M, Biniossek ML, Walz G, Werner M, Endlich N, Schilling O, Huber TB, Schell C. J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561 [Abstract] [Full Text] [Related]
2. ARHGEF7 (β-PIX) Is Required for the Maintenance of Podocyte Architecture and Glomerular Function. Matsuda J, Maier M, Aoudjit L, Baldwin C, Takano T. J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698 [Abstract] [Full Text] [Related]
3. The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier. Schell C, Rogg M, Suhm M, Helmstädter M, Sellung D, Yasuda-Yamahara M, Kretz O, Küttner V, Suleiman H, Kollipara L, Zahedi RP, Sickmann A, Eimer S, Shaw AS, Kramer-Zucker A, Hirano-Kobayashi M, Abe T, Aizawa S, Grahammer F, Hartleben B, Dengjel J, Huber TB. Proc Natl Acad Sci U S A; 2017 Jun 06; 114(23):E4621-E4630. PubMed ID: 28536193 [Abstract] [Full Text] [Related]
4. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. George B, Verma R, Soofi AA, Garg P, Zhang J, Park TJ, Giardino L, Ryzhova L, Johnstone DB, Wong H, Nihalani D, Salant DJ, Hanks SK, Curran T, Rastaldi MP, Holzman LB. J Clin Invest; 2012 Feb 06; 122(2):674-92. PubMed ID: 22251701 [Abstract] [Full Text] [Related]
5. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling. Qiao Y, Wang P, Chang M, Chen B, Ge Y, Malhotra DK, Dworkin LD, Gong R. Clin Sci (Lond); 2020 Apr 17; 134(7):695-710. PubMed ID: 32167144 [Abstract] [Full Text] [Related]
6. α-Parvin Defines a Specific Integrin Adhesome to Maintain the Glomerular Filtration Barrier. Rogg M, Maier JI, Van Wymersch C, Helmstädter M, Sammarco A, Lindenmeyer M, Zareba P, Montanez E, Walz G, Werner M, Endlich N, Benzing T, Huber TB, Schell C. J Am Soc Nephrol; 2022 Apr 17; 33(4):786-808. PubMed ID: 35260418 [Abstract] [Full Text] [Related]
7. Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury. Subramanian B, Sun H, Yan P, Charoonratana VT, Higgs HN, Wang F, Lai KV, Valenzuela DM, Brown EJ, Schlöndorff JS, Pollak MR. Kidney Int; 2016 Aug 17; 90(2):363-372. PubMed ID: 27350175 [Abstract] [Full Text] [Related]
8. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics. Meliambro K, Wong JS, Ray J, Calizo RC, Towne S, Cole B, El Salem F, Gordon RE, Kaufman L, He JC, Azeloglu EU, Campbell KN. J Biol Chem; 2017 Dec 22; 292(51):21137-21148. PubMed ID: 28982981 [Abstract] [Full Text] [Related]
9. Activation of RhoA in podocytes induces focal segmental glomerulosclerosis. Zhu L, Jiang R, Aoudjit L, Jones N, Takano T. J Am Soc Nephrol; 2011 Sep 22; 22(9):1621-30. PubMed ID: 21804090 [Abstract] [Full Text] [Related]
10. Rho GTPase regulatory proteins in podocytes. Matsuda J, Asano-Matsuda K, Kitzler TM, Takano T. Kidney Int; 2021 Feb 22; 99(2):336-345. PubMed ID: 33122025 [Abstract] [Full Text] [Related]
11. Rho-GTPase Activating Protein myosin MYO9A identified as a novel candidate gene for monogenic focal segmental glomerulosclerosis. Li Q, Gulati A, Lemaire M, Nottoli T, Bale A, Tufro A. Kidney Int; 2021 May 22; 99(5):1102-1117. PubMed ID: 33412162 [Abstract] [Full Text] [Related]
12. SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion. Fan X, Yang H, Kumar S, Tumelty KE, Pisarek-Horowitz A, Rasouly HM, Sharma R, Chan S, Tyminski E, Shamashkin M, Belghasem M, Henderson JM, Coyle AJ, Salant DJ, Berasi SP, Lu W. JCI Insight; 2016 Nov 17; 1(19):e86934. PubMed ID: 27882344 [Abstract] [Full Text] [Related]
13. Vinculin is required to maintain glomerular barrier integrity. Lausecker F, Tian X, Inoue K, Wang Z, Pedigo CE, Hassan H, Liu C, Zimmer M, Jinno S, Huckle AL, Hamidi H, Ross RS, Zent R, Ballestrem C, Lennon R, Ishibe S. Kidney Int; 2018 Mar 17; 93(3):643-655. PubMed ID: 29241625 [Abstract] [Full Text] [Related]
14. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury. Potla U, Ni J, Vadaparampil J, Yang G, Leventhal JS, Campbell KN, Chuang PY, Morozov A, He JC, D'Agati VD, Klotman PE, Kaufman L. J Clin Invest; 2014 Apr 17; 124(4):1757-69. PubMed ID: 24642466 [Abstract] [Full Text] [Related]
15. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage. Sachs M, Wetzel S, Reichelt J, Sachs W, Schebsdat L, Zielinski S, Seipold L, Heintz L, Müller SA, Kretz O, Lindenmeyer M, Wiech T, Huber TB, Lüllmann-Rauch R, Lichtenthaler SF, Saftig P, Meyer-Schwesinger C. J Am Soc Nephrol; 2021 Jun 01; 32(6):1389-1408. PubMed ID: 33785583 [Abstract] [Full Text] [Related]
16. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS. Niculovic KM, Blume L, Wedekind H, Kats E, Albers I, Groos S, Abeln M, Schmitz J, Beuke E, Bräsen JH, Melk A, Schiffer M, Weinhold B, Münster-Kühnel AK. J Am Soc Nephrol; 2019 Jun 01; 30(6):1021-1035. PubMed ID: 31040189 [Abstract] [Full Text] [Related]
17. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. Chen CA, Hwang JC, Guh JY, Chang JM, Lai YH, Chen HC. J Lab Clin Med; 2006 Feb 01; 147(2):74-82. PubMed ID: 16459165 [Abstract] [Full Text] [Related]
18. Proteome Analysis of Isolated Podocytes Reveals Stress Responses in Glomerular Sclerosis. Koehler S, Kuczkowski A, Kuehne L, Jüngst C, Hoehne M, Grahammer F, Eddy S, Kretzler M, Beck BB, Höhfeld J, Schermer B, Benzing T, Brinkkoetter PT, Rinschen MM. J Am Soc Nephrol; 2020 Mar 01; 31(3):544-559. PubMed ID: 32047005 [Abstract] [Full Text] [Related]
19. Plekhh2, a novel podocyte protein downregulated in human focal segmental glomerulosclerosis, is involved in matrix adhesion and actin dynamics. Perisic L, Lal M, Hulkko J, Hultenby K, Önfelt B, Sun Y, Dunér F, Patrakka J, Betsholtz C, Uhlen M, Brismar H, Tryggvason K, Wernerson A, Pikkarainen T. Kidney Int; 2012 Nov 01; 82(10):1071-83. PubMed ID: 22832517 [Abstract] [Full Text] [Related]
20. Epithelial cell foot process effacement in podocytes in focal and segmental glomerulosclerosis: a quantitative analysis. Kfoury H. Ultrastruct Pathol; 2014 Oct 01; 38(5):303-8. PubMed ID: 24956069 [Abstract] [Full Text] [Related] Page: [Next] [New Search]